ICAD. iCAD Launches New VersaVue MR Software at RSNA 2012

New Post Public Reply Private Reply Replies (0) Message Board

Nov 25, 2012 at 3:18 PM

ICAD. iCAD Launches New VersaVue MR Software at RSNA 2012

Company to Showcase Latest Version of MR Image Analysis Suite Along with New PowerLook Advanced Mammography Platform for First Time at RSNA
http://finance.yahoo.com/news/icad-launches-v...00050.html

CHICAGO--(BUSINESS WIRE)--

iCAD, Inc. (ICAD), an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the identification and treatment of cancer, announced today it will launch VersaVue Enterprise 3.2.1, the latest release of the company’s MR software solution that provides improvements in workflow efficiency and flexibility, at the annual conference of the Radiological Society of North America (RSNA) taking place in Chicago, November 25-30.

“iCAD is committed to developing the most comprehensive, sophisticated image analysis solutions to help clinicians increase efficiency and diagnostic confidence,” said Ken Ferry, President and CEO of iCAD. “The new VersaVue Enterprise solution will improve workflow and flexibility to aid clinical decision making and treatment for patients, with an ultimate goal of delivering improved patient care.”

VersaVue provides robust Dynamic Contrast Enhanced (DCE) MR image analysis and flexible review and reporting tools that facilitate standardization of kinetic analysis and interpretation and reporting of morphology. Using advanced thin client architecture, VersaVue delivers real-time data access and eliminates the need to purchase redundant hardware. The software features on-demand viewing of studies anytime, anywhere to speed workflow as well as shared knowledge of study status from a single, shared database. Unique features of VersaVue Enterprise 3.2.1 include:

Fusion of ADC color overlays on any sequence
On the fly 3 time point calculation (Quick TP)
Fully automatic prostate segmentation of the capsule that will allow prostate volume reporting

VersaVue Enterprise is part of iCAD’s complete MRI product suite which includes SpectraLook®, VividLook® and OmniLook®. These products offer comprehensive quantitative image analysis for cancer detection, staging, localization, treatment planning and serial monitoring.

iCAD will also be highlighting two prostate biopsy solutions at RSNA:

MRI Guided Prostate Biopsy (Currently pending FDA 510k clearance)

This solution will be a second generation system that will take advantage of the MR scanners gradient fields along with an innovative biopsy needle positioning device that is designed to provide radiologists with easier patient set-up, reduce the number of scans to identify and calculate target coordinates and reduce the total patient time in the magnet. The MRI guided solution is a works in progress project.

MR TRUS Fusion for Prostate Biopsy

The current TRUS procedure has limitations in target hit rate and accuracy. This next generation solution will improve target hit rate and accuracy, color coding significant tracks by Gleason scores and storing those tracks to compare for repeat biopsies particularly important for patients under active surveillance. The system uses a unique organ based tracking technology using 3D end-fire ultrasound probe and elastic Fusion technology to fuse MR with US images. MR TRUS Fusion is a solution that has product compatibility with the VersaVue Enterprise MR solution. With VersaVue Enterprise 3.2.1 release there will be expanded features that will be compatible with the MR TRUS Fusion solution.

Additionally, iCAD’s workstation was used to process the MR images used in a neuroradiology study that examined brain meningiomas. A scientific paper presenting the study’s findings titled, “Intracranial Tumor Extravascular Extracellular Space: Examining the Correlation Between ADC and DCE MRI Metrics in Human Meningioma,” will be presented at RSNA on Tuesday, November 27 at 3:30 p.m. in room N226.

iCAD will also showcase its next generation computer-aided detection (CAD) system for digital mammography, the PowerLook Advanced Mammography Platform (AMP). The modular design of PowerLook AMP provides radiologists with the ability to customize their CAD solution to meet the needs of their individual work environment today and in the future. The technology expands on iCAD’s SecondLook Digital solution and is the CAD platform upon which all future breast imaging CAD offerings from iCAD will be built. PowerLook AMP’s CAD metrics offer industry-leading tissue and lesion characteristics to support the breast imager’s workflow. In addition, PowerLook AMP is the first product of its kind to integrate M?takina’s Volpara® Volumetric Breast Density assessment software that aids radiologists by standardizing their approach to breast density assessment.

About iCAD, Inc.

iCAD is an industry-leading provider of Computer-Aided Detection (CAD) technologies, advanced image analysis, workflow solutions and radiation therapies for the early identification and treatment of common cancers. iCAD offers a comprehensive range of high-performance, upgradeable CAD solutions for mammography and advanced image analysis and workflow solutions for Magnetic Resonance Imaging, for breast and prostate cancers and Computed Tomography for colorectal cancer. iCAD’s Xoft System, offers radiation treatment for early-stage breast cancer that can be administered in the form of intraoperative radiation therapy or accelerated partial breast irradiation. The Xoft System is also cleared for the treatment of non-melanoma skin cancer and endometrial cancer. For more information, call (877) iCADnow, or visit www.icadmed.com.

chart.

http://stockcharts.com/h-sc/ui?s=ICAD&p=D...9087506105

Featured stocks: Coffee Shoppe
For conservative debate: "Keeping it Real"
Game Changing stock $SHMP

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

SVRN Taps Industry Vet Patrick O'Kain as COO

SVRN Aims for New Heights with a Savvy Hire If there’s one thing veteran market-watchers like myself know, it’s that leadership shifts can tell you more about a company’s guts than any press release. SVRN (NASDAQ: SVRN), a name with one foot firmly in the world of digital assets, just snagged Patrick O’Kain for their COO spot. They're not playing around, folks,...

Annual Home Insurance Check: Paul Bernieri's Top Tips

Don't Sleep on Your Annual Insurance Review Ever feel like insurance policy reviews are one of those boring chores? Well, Paul Bernieri would probably say they're anything but. In a recent HelloNation article, our favorite insurance expert, Paul Bernieri from Garden City, NY, dissects the crucial areas homeowners on Long Island need to examine each year. It's basically a...

CVS Health Boosts 2026 Guidance Amid Revenue Jump

A Solid Quarter for CVS Health CVS Health Corporation has once again turned heads with its third-quarter 2026 results. When you're pulling $108.4 billion in quarterly revenue, up 5.4% from last year, folks notice. Adjusted earnings hit $2.09 per share, climbing a respectable 30% from $1.60 the year before. The cherry on top? A big fat boost in 2026 guidance, signaling...

NACCO Navigates Strong 2026 Q3, Faces Solar Cost Hurdles

Rolling With NACCO's Financial Punches Well, folks, when it rains, it pours—numbers that is. NACCO Industries just laid out their Q3 results for all to gawk at, and it's a mixed bag of triumphs and tussles. You got a gross profit of $11.8 million, a sweet 18% jump on the same quarter last year. Now, you're talking about revenue muscle, and there it is. Income before...

WellNet Embraces Voice AI for Provider Calls

Ever met a TPA grappling over their provider call costs like a crusty sailor with a rusted anchor? Welcome to WellNet Healthcare, folks. They've tapped EHVAhealth's conversational voice AI to take a solid swing at automating those burdensome provider calls. They're no stranger to the chaos of managing member eligibility and benefits verification, and this move might just...

KFC Teams with Marvel for Record-Breaking Menu Launch

Movie Magic on the Menu When was the last time a bucket of fried chicken sent such ripple effects through pop culture? KFC's decision to sling Doctor Doom-inspired dishes across 100 countries smells like genius business mixed with a dash of the absurd. Just imagine: an empire of battered birds aligning with Marvel's latest cinematic heavy hitter, "Avengers: Doomsday." Now...

Everest Group Faces Shaky Ground in Securities Fraud Suit

Investors Take Aim at Everest Group's Alleged Missteps Looks like Everest Group, Ltd. (NYSE: EG) has found itself knee-deep in legal quicksand. There's a class-action lawsuit afoot, spearheaded by the folks at Schall, Brown & Schwartz LLP. They're putting forward claims that Everest, a player in the securities exchange, was painting a misleading picture when it came to...

Zillow Eases the FHA Down Payment Burden

A New Financial Lifeline for Homebuyers In a market where finding a foothold in the housing game feels like scaling Everest without ropes, Zillow Home Loans has tossed a lifeline to potential homeowners. Their latest move might just be what many house hunters needed to hear—offering a hand where it’s been missing for years: down payment assistance for FHA loans. The...

Life with PAH: A Journey of Awareness and Hope

Unearthing the Hidden Struggle of PAH The American Lung Association (ALA) is getting loud about a quiet killer—pulmonary arterial hypertension (PAH) is in their spotlight this month, and it's about time. Documenting the horror stories of some 500 to 1,000 new PAH diagnoses each year in the U.S., the ALA is peeling back the blinds on a condition that's too often...

Systemair Wins First Natural Refrigerant Heat Pump Deal

Systemair Breaks New Ground Hold onto your hats, because Systemair just sealed a deal that's going to make waves. Their recent accomplishment isn't just some humdrum business tedium—it's an intriguing step forward in the HVAC world. Systemair snagged their very first order for air handling units featuring an integrated heat pump and natural refrigerant. You've got to...